BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9649305)

  • 1. A single amino acid substitution changes ribonuclease 4 from a uridine-specific to a cytidine-specific enzyme.
    Hofsteenge J; Moldow C; Vicentini AM; Zelenko O; Jarai-Kote Z; Neumann U
    Biochemistry; 1998 Jun; 37(26):9250-7. PubMed ID: 9649305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of the uridine-preferring specificity of RNase PL3.
    Vicentini AM; Kote-Jarai Z; Hofsteenge J
    Biochemistry; 1996 Jul; 35(28):9128-32. PubMed ID: 8703917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residues 36-42 of liver RNase PL3 contribute to its uridine-preferring substrate specificity. Cloning of the cDNA and site-directed mutagenesis studies.
    Vicentini AM; Hemmings BA; Hofsteenge J
    Protein Sci; 1994 Mar; 3(3):459-66. PubMed ID: 8019417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of the ribonuclease MC1 from bitter gourd seeds, complexed with 2'-UMP or 3'-UMP, reveal structural basis for uridine specificity.
    Suzuki A; Yao M; Tanaka I; Numata T; Kikukawa S; Yamasaki N; Kimura M
    Biochem Biophys Res Commun; 2000 Aug; 275(2):572-6. PubMed ID: 10964705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A residue to residue hydrogen bond mediates the nucleotide specificity of ribonuclease A.
    delCardayré SB; Raines RT
    J Mol Biol; 1995 Sep; 252(3):328-36. PubMed ID: 7563054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
    Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
    J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coulombic forces in protein-RNA interactions: binding and cleavage by ribonuclease A and variants at Lys7, Arg10, and Lys66.
    Fisher BM; Ha JH; Raines RT
    Biochemistry; 1998 Sep; 37(35):12121-32. PubMed ID: 9724524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coulombic effects of remote subsites on the active site of ribonuclease A.
    Fisher BM; Schultz LW; Raines RT
    Biochemistry; 1998 Dec; 37(50):17386-401. PubMed ID: 9860854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity.
    Terzyan SS; Peracaula R; de Llorens R; Tsushima Y; Yamada H; Seno M; Gomis-Rüth FX; Coll M
    J Mol Biol; 1999 Jan; 285(1):205-14. PubMed ID: 9878400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of double-stranded RNA by human pancreatic ribonuclease: crucial role of noncatalytic basic amino acid residues.
    Sorrentino S; Naddeo M; Russo A; D'Alessio G
    Biochemistry; 2003 Sep; 42(34):10182-90. PubMed ID: 12939146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the structural and functional properties of RNase A and BS-RNase: a stepwise mutagenesis approach.
    Ercole C; Colamarino RA; Pizzo E; Fogolari F; Spadaccini R; Picone D
    Biopolymers; 2009 Dec; 91(12):1009-17. PubMed ID: 19263489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uridine kinase: altered enzyme with decreased affinities for uridine and CTP.
    Ropp PA; Traut TW
    Arch Biochem Biophys; 1998 Nov; 359(1):63-8. PubMed ID: 9799561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure and structure-based mutational analyses of RNase HIII from Bacillus stearothermophilus: a new type 2 RNase H with TBP-like substrate-binding domain at the N terminus.
    Chon H; Matsumura H; Koga Y; Takano K; Kanaya S
    J Mol Biol; 2006 Feb; 356(1):165-78. PubMed ID: 16343535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altering substrate specificity of phosphatidylcholine-preferring phospholipase C of Bacillus cereus by random mutagenesis of the headgroup binding site.
    Antikainen NM; Hergenrother PJ; Harris MM; Corbett W; Martin SF
    Biochemistry; 2003 Feb; 42(6):1603-10. PubMed ID: 12578373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural features that determine the enzymatic potency and specificity of human angiogenin: threonine-80 and residues 58-70 and 116-123.
    Shapiro R
    Biochemistry; 1998 May; 37(19):6847-56. PubMed ID: 9578571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amino acid sequence of human ribonuclease 4, a highly conserved ribonuclease that cleaves specifically on the 3' side of uridine.
    Zhou HM; Strydom DJ
    Eur J Biochem; 1993 Oct; 217(1):401-10. PubMed ID: 8223579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of amino-acid residue 95 in substrate specificity of phosphagen kinases.
    Tanaka K; Suzuki T
    FEBS Lett; 2004 Aug; 573(1-3):78-82. PubMed ID: 15327979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of pyridine nucleotide specificity of nitrate reductase: mutagenesis of recombinant cytochrome b reductase fragment of Neurospora crassa NADPH:Nitrate reductase.
    Shiraishi N; Croy C; Kaur J; Campbell WH
    Arch Biochem Biophys; 1998 Oct; 358(1):104-15. PubMed ID: 9750171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41.
    Holloway DE; Chavali GB; Hares MC; Baker MD; Subbarao GV; Shapiro R; Acharya KR
    Biochemistry; 2004 Feb; 43(5):1230-41. PubMed ID: 14756559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of the ribonuclease MC1 mutants N71T and N71S in complex with 5'-GMP: structural basis for alterations in substrate specificity.
    Numata T; Suzuki A; Kakuta Y; Kimura K; Yao M; Tanaka I; Yoshida Y; Ueda T; Kimura M
    Biochemistry; 2003 May; 42(18):5270-8. PubMed ID: 12731868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.